Our Story
Patient-focused Pharmaceutical Group
EPM is developing prescription medicine based on novel discoveries of synthetic cannabinoid acids to address unmet patient needs. These innovations represent new treatment options and aim at alleviating a wide range of therapeutic conditions for millions of patients worldwide.